- Home
- CNFR vs INBS Comparison
CNFR vs INBS Comparison
Compare CNFR & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNFR
- INBS
- Stock Information
- Founded
- CNFR 2009
- INBS 2016
- Country
- CNFR United States
- INBS United States
- Employees
- CNFR N/A
- INBS N/A
- Industry
- CNFR Property-Casualty Insurers
- INBS Medical Specialities
- Sector
- CNFR Finance
- INBS Health Care
- Exchange
- CNFR Nasdaq
- INBS Nasdaq
- Market Cap
- CNFR 7.9M
- INBS 8.7M
- IPO Year
- CNFR 2015
- INBS N/A
- Fundamental
- Price
- CNFR $0.84
- INBS $1.41
- Analyst Decision
- CNFR
- INBS
- Analyst Count
- CNFR 0
- INBS 0
- Target Price
- CNFR N/A
- INBS N/A
- AVG Volume (30 Days)
- CNFR 15.5K
- INBS 127.7K
- Earning Date
- CNFR 05-14-2025
- INBS 05-13-2025
- Dividend Yield
- CNFR N/A
- INBS N/A
- EPS Growth
- CNFR N/A
- INBS N/A
- EPS
- CNFR 1.96
- INBS N/A
- Revenue
- CNFR $64,021,000.00
- INBS $2,936,472.00
- Revenue This Year
- CNFR $25.91
- INBS $280.88
- Revenue Next Year
- CNFR N/A
- INBS $126.26
- P/E Ratio
- CNFR $0.43
- INBS N/A
- Revenue Growth
- CNFR N/A
- INBS 3.87
- 52 Week Low
- CNFR $0.42
- INBS $1.00
- 52 Week High
- CNFR $1.91
- INBS $3.00
- Technical
- Relative Strength Index (RSI)
- CNFR 60.78
- INBS 54.99
- Support Level
- CNFR $0.74
- INBS $1.18
- Resistance Level
- CNFR $0.87
- INBS $1.57
- Average True Range (ATR)
- CNFR 0.04
- INBS 0.11
- MACD
- CNFR 0.00
- INBS 0.03
- Stochastic Oscillator
- CNFR 83.10
- INBS 60.98
About CNFR Conifer Holdings Inc.
Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).